EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Advances in breast cancer screening modalities and status of global screening programs

Chenyu Luo iD, Le Wang, Yuhan Zhang, Ming Lu, Bin Lu, Jie Cai, Hongda Chen iD, Min Dai

Chronic Diseases and Translational Medicine · 2022-06 · 8 (2) · 112-123

DOI: 10.1002/cdt3.21 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Chronic Diseases and Translational Medicine, online erschienen am 25.05.2022. Verfasst von Chenyu Luo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Medical Research Center, Peking Union Medical College Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Natural Science Foundation of Beijing Municipality.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast cancer (BC) is the most prevalent malignancy worldwide, and a continued upward trend has been predicted in the coming decades. Screening in selected targeted populations, which is effective in reducing cancer‐related mortality, has been widely implemented in many countries. This review summarizes the advances in BC screening techniques, organized or opportunistic BC screening programs across different countries, and screening modalities recommended by different academic authorities. Mammography is the most widely used and effective technique for BC screening. Other complementary techniques include ultrasound, clinical breast examination, and magnetic resonance imaging. Novel screening tests, including digital breast tomosynthesis and liquid biopsies, are still under development. Globally, the implementation status of BC screening programs is uneven, which is reflected by differences in screening modes, techniques, and population coverage. The recommended optimal screening strategies varied according to the authoritative guidelines. The effectiveness of current screening programs is influenced by several factors, including low detection rate, high false‐positive rate, and unsatisfactory coverage and uptake rates. Exploration of accurate BC risk prediction models and the development of risk‐stratified screening strategies are highly warranted in future research.

Schlagwörter

Stichwörter der Autor:innen

breast cancerguidelinemammographyscreeningultrasound

Autor:innen und Institutionen

  • Medical Research Center, Peking Union Medical College Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China.
  • Department of Cancer Prevention Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital) Hangzhou Zhejiang China.
  • Department of General Surgery, Peking Union Medical College Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China.

ORCID-Profile: Chenyu Luo, Hongda Chen

Förderung

  • Natural Science Foundation of Beijing Municipality

Zitieren

APA

Luo, C., Wang, L., Zhang, Y., Lu, M., Lu, B., Cai, J., Chen, H., & Dai, M. (2022). Advances in breast cancer screening modalities and status of global screening programs. Chronic Diseases and Translational Medicine, 8(2), 112-123. https://doi.org/10.1002/cdt3.21

Vancouver

Luo C, Wang L, Zhang Y, Lu M, Lu B, Cai J, et al. Advances in breast cancer screening modalities and status of global screening programs. Chronic Diseases and Translational Medicine. 2022;8(2):112-123. doi:10.1002/cdt3.21

BibTeX
@article{Luo2022,
  author = {Luo, Chenyu and Wang, Le and Zhang, Yuhan and Lu, Ming and Lu, Bin and Cai, Jie and Chen, Hongda and Dai, Min},
  title = {Advances in breast cancer screening modalities and status of global screening programs},
  journal = {Chronic Diseases and Translational Medicine},
  year = {2022},
  volume = {8},
  number = {2},
  pages = {112--123},
  doi = {10.1002/cdt3.21}
}
Kostenlos starten →